NoticiasCon ayuda de IA

Alvotech Appoints DNB Carnegie As Liquidity Provider For SDRs On Nasdaq Stockholm

Alvotech appoints DNB Carnegie as liquidity provider for its SDRs on Nasdaq Stockholm to enhance trading stability.

Vaibhavi M.
Por Vaibhavi M.
Experto en la materia (B.Pharm) · Pharma Now
20 may 2025Updated Jun 26, 2025 · 2 min de lectura
Alvotech Appoints DNB Carnegie As Liquidity Provider For SDRs On Nasdaq Stockholm
Reportaje con ayuda de IA
Reviewed by Vaibhavi M., Experto en la materia (B.Pharm) · Pharma Now

Alvotech has announced an agreement with DNB Carnegie Investment Bank AB to act as a liquidity provider for the company's Swedish Depository Receipts (SDRs), which trade on Nasdaq Stockholm. This arrangement is designed to support trading activity and improve market liquidity for Alvotech's SDRs, which represent equity shares in the company.

DNB Carnegie will always give buy and sell quotes for Alvotech’s SDRs, as required by Nasdaq Stockholm’s rules for liquidity providers. As a result, investors are expected to have more confidence in the company’s SDRs trading environment, and there should be less fluctuation in prices. DNB Carnegie’s liquidity provision will begin on May 20, 2025.

Vaibhavi M.
Written by
Vaibhavi M.
Experto en la materia (B.Pharm) · Pharma Now

Reporting on the science, business and regulation shaping the pharmaceutical industry.

Discussion

Cargando la conversación…

Más de Pharma News

Todos los artículos →